Melanoma patients live longer on Roche's Avastin | Reuters

Links shared publicly online about this topic.

  • 1,732
    total visits

Melanoma patients live longer on Roche's Avastin | Reuters

reuters.com

BERLIN (Reuters) - Patients with melanoma, a notoriously difficult to treat cancer of the skin, live longer when given Roche's drug Avastin, according to a scientific abstract from Europe's top cancer

View full resource at reuters.com

Tags: Skin, Cancer, Colorectal Cancer Medication, Skin Cancer, Melanoma, Avastin

  • Share

Most Recently Shared on September 21, 2009 at 7:09 pm By:

Roche's Avastin helps colorectal cancer patients | Reuters

reuters.com — “ZURICH (Reuters) - Patients with advanced colorectal cancer who received Roche's Avastin live longer when they also receive the drug as part of their second round of treatment, the Swiss drugmaker saidView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on January 26, 2012 at 8:07 am By:

HealthNews2 Health News Health News

Roche's Avastin helps colorectal cancer patients: ZURICH (Reuters) - Patients with advanced colore... http://t.co/8hqtdZbJ #health #news

3 months ago...

Roche melanoma drug helps patients live longer | Reuters

reuters.com — “ZURICH (Reuters) - Swiss drugmaker Roche's new treatment for advanced skin cancer helps patients live longer and also extends the period in which their disease does not get worse, a late-stage trial hasView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on January 20, 2011 at 2:33 am By:

Reuters_Health Reuters Health Health News

Roche melanoma drug helps patients live longer http://reut.rs/hHdcDh

1 year ago...

Roche melanoma drug helps patients live longer - QualityPoint Technologies

qualitypointtech.net — “ZURICH (Reuters) - Swiss drugmaker Roche's new treatment for advanced skin cancer helps patients live longer and also extends the period in which their disease does not get worse, a late-stage trial has shown. (Source: Reuters: Health)View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on January 19, 2011 at 9:01 am By:

MedicalFeed MedicalFeed Health News Feed

Roche melanoma drug helps patients live longer: ZURICH (Reuters) - Swiss drugmaker Roche's new treatment for adva... http://bit.ly/fhLlOI

1 year ago...

Roche melanoma drug helps patients live longer | Reuters

reuters.com — “ZURICH (Reuters) - Swiss drugmaker Roche's new treatment for advanced skin cancer helps patients live longer and also extends the period in which their disease does not get worse, a late-stage trial hasView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on January 19, 2011 at 7:48 am By:

MedicalNews Medical News Health News

Roche melanoma drug helps patients live longer http://bit.ly/ezkPNt

1 year ago...

Sustained Avastin aids colon cancer survival: study | Reuters

reuters.com — “LOS ANGELES (Reuters) - Colorectal cancer patients who continued treatment with Roche Holding AG's Avastin even after their cancer worsened lived longer than those who went off the drug, according to anView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on May 21, 2010 at 11:08 am By:

HealthNews2 Health News Health News

Sustained Avastin aids colon cancer survival: study: LOS ANGELES (Reuters) - Colorectal cancer patien... http://bit.ly/bTPSPB #health #news

2 years ago...

Sustained Avastin aids colon cancer survival: study | Reuters

reuters.com — “LOS ANGELES (Reuters) - Colorectal cancer patients who continued treatment with Roche Holding AG's Avastin even after their cancer worsened lived longer than those who went off the drug, according to anView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on May 21, 2010 at 10:57 am By:

Reuters_Health Reuters Health Health News

Sustained Avastin aids colon cancer survival: study http://link.reuters.com/peg65k

2 years ago...

Sustained Avastin aids colon cancer survival-study | Reuters

reuters.com — “LOS ANGELES (Reuters) - Colorectal cancer patients who continued treatment with Roche Holding AG's Avastin even after their cancer worsened lived longer than those who went off the drug, according to anView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on May 20, 2010 at 10:57 pm By:

Advertisement